Definition: Gestational Diabetes Mellitus (GDM) is any degree of glucose intolerance first recognised or diagnosed during pregnancy, regardless of whether it pre-dated the pregnancy or persists after delivery.
Universal GCC Screening
GCC countries apply universal screening for all pregnant women due to extremely high background T2DM prevalence. High-risk women are screened from booking; all others at 24–28 weeks.
Standard timing24–28 weeks gestation
High-risk timingFrom booking visit + repeat 24–28 wks
Test of choice75g 2-hour OGTT (WHO/IADPSG)
Risk Factors
- BMI >30 kg/m² (obesity)
- Previous GDM in prior pregnancy
- Previous macrosomic baby (>4.5 kg)
- First-degree relative with T2DM
- PCOS (polycystic ovary syndrome)
- South Asian / Middle Eastern ethnicity
- Glycosuria on dipstick ≥2 occasions
- Multiple pregnancy / IVF conception
- Polyhydramnios / large-for-dates fetus
- Unexplained stillbirth history
- Age >35 years
Diagnostic Criteria — 75g Oral Glucose Tolerance Test (OGTT)
WHO / IADPSG Criteria (used across GCC)
GDM is diagnosed if ANY ONE of the following thresholds is met or exceeded on the 75g 2-hour OGTT:
| Time Point | Threshold (mmol/L) | Threshold (mg/dL) | Significance |
|---|---|---|---|
| Fasting | ≥ 5.1 | ≥ 92 | Most sensitive single value |
| 1-hour | ≥ 10.0 | ≥ 180 | Reflects post-load glucose excursion |
| 2-hour | ≥ 8.5 | ≥ 153 | Confirms impaired clearance |
* Based on HAPO Study data. IADPSG 2010. Adopted by WHO 2013. Used in UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain.
HbA1c at Booking Visit
- HbA1c ≥48 mmol/mol (≥6.5%) = probable pre-existing T2DM → refer to diabetologist urgently
- HbA1c 39–47 mmol/mol (5.7–6.4%) = high risk / pre-diabetes → early OGTT + lifestyle advice
- HbA1c NOT reliable in haemoglobinopathy (common in GCC) — use fasting glucose instead
- HbA1c unreliable after 20 weeks — use OGTT as gold standard
OGTT Procedure — Nursing Role
Patient fasts 8–14 hours (water allowed). Confirm no illness, recent steroids, or acute stress.
Draw fasting venous sample (fluoride oxalate tube). Record time and patient weight.
Administer 75g anhydrous glucose dissolved in 250–300ml water. Patient to drink within 5 minutes.
Patient rests — no eating, smoking, or exercise during test. Note any nausea/vomiting.
Draw 1-hour venous sample (optional at some centres) and 2-hour venous sample. Label all tubes accurately.
Communicate results to obstetric team same day. Document clearly in antenatal notes.
Classification After Testing
Normal
All values below diagnostic thresholds. Retest at 32 weeks if clinical concern or new risk factor develops.
GDM Confirmed
Any one value meets/exceeds threshold. Refer to combined obstetric-diabetes team. Commence MNT immediately.
Overt T2DM in Pregnancy
Fasting ≥7.0 mmol/L OR 2-hour ≥11.1 mmol/L OR HbA1c ≥48 mmol/mol. Higher risk — urgent diabetologist input, consider insulin from diagnosis.
GCC Note: GDM prevalence in GCC countries ranges from 16–26% — among the highest globally. Nurses must treat GDM screening as a routine, high-priority antenatal task. Do not wait for symptomatic presentation.
First-line management: Medical Nutrition Therapy (MNT) combined with physical activity is the cornerstone of GDM management. 70–80% of women achieve target glucose control on MNT alone.
Medical Nutrition Therapy (MNT)
Total calories1800–2200 kcal/day (adjust for BMI)
Obese women (BMI>30)Max 30% caloric restriction — avoid ketosis
Carbohydrate proportion35–45% of total calories
Protein20–25%
Fat30–40% (unsaturated preferred)
Fibre≥28g/day
Fluid8–10 glasses water/day
Meal Pattern & Distribution
- 3 main meals + 2–3 planned snacks per day
- Avoid skipping meals — causes hypoglycaemia risk on insulin
- Distribute carbohydrates evenly — no single large carbohydrate load
- Breakfast: limit to 15–30g carbs (morning insulin resistance highest)
- Mid-morning + mid-afternoon snacks: 15–20g carbs each
- Evening snack if on insulin: 20–25g carbs to prevent nocturnal hypoglycaemia
- Large gaps (>4h) between eating → increases ketone production
Glycaemic Index & Food Choices
Preferred Low-GI Foods
- Basmati rice (small portion — ½ cup cooked)
- Whole grain bread / seeded bread
- Lentils, chickpeas, beans (hummus — excellent)
- Non-starchy vegetables (salad, cucumber, tomato)
- Full-fat plain yoghurt / labneh
- Eggs, lean meat, chicken, fish
- Nuts (handful — almonds, walnuts)
- Olive oil / avocado
- Berries (lower sugar fruit)
- Oats / high-fibre cereals
Limit / Avoid
- White rice in large portions (staple in GCC — requires portion management)
- Dates — very high in sugar (2–3 dates only, eaten with protein)
- Sugary juices, soft drinks, cordials
- White bread / flatbreads in large amounts
- Halwa, baklava, luqaimat (high sugar Arabic sweets)
- Mangoes, grapes, bananas — high GI fruits (limit to small portions)
- Deep-fried foods (samosa, fatayer — common in GCC)
- Condensed milk / sweetened dairy
- Cooking in excess ghee or palm oil
Physical Activity
Exercise Recommendations in GDM
- 150 minutes/week moderate-intensity aerobic activity (30 min most days)
- Brisk walking most effective and accessible in GCC
- Post-meal walking (10–15 min after each meal) significantly reduces post-prandial glucose
- Swimming: safe in all trimesters
- Resistance exercises improve insulin sensitivity
Obstetric contraindications to exercise:
- Placenta praevia
- Threatened preterm labour
- Incompetent cervix / cerclage
- Significant heart or lung disease
- Severe pre-eclampsia
- Always confirm with obstetrician before advising exercise
GCC Climate Note: Extreme summer heat (45–50°C) limits outdoor activity. Advise indoor exercise (malls, gym, home treadmill). Early morning / late evening outdoor walking acceptable in cooler months. Hydration is critical.
Blood Glucose Monitoring Targets
| Monitoring Time | Target (mmol/L) | Target (mg/dL) | Action if Exceeded |
|---|---|---|---|
| Fasting (on waking) | ≤ 5.3 | ≤ 95 | Review bedtime snack; consider basal insulin if persistent |
| 1-hour post-meal | ≤ 7.8 | ≤ 140 | Review meal carbohydrate content; add pre-meal insulin if on insulin therapy |
| 2-hour post-meal | ≤ 6.7 | ≤ 120 | Reassess dietary adherence; medication review |
| Hypoglycaemia threshold | < 3.5 | < 63 | Treat immediately — 15g fast-acting carbohydrate. Recheck in 15 min. |
Glucose Diary — Nursing Education Points
- Test fasting daily; post-meal testing rotates (breakfast 1 day, lunch next, dinner following)
- Record all readings with time, meal eaten, and any unusual activity or illness
- Bring diary to every antenatal appointment for review
- Digital glucometer downloads (if available) can be reviewed in clinic
- 3 or more consecutive above-target readings at same time point → contact team
- Do not interpret results independently — always involve diabetes team
Pharmacological trigger: If blood glucose targets are not met after 1–2 weeks of optimal MNT, pharmacological therapy must be commenced promptly to avoid fetal complications from prolonged hyperglycaemia.
Insulin Therapy — First-Line Pharmacological Treatment
Why Insulin is Preferred
- Does not cross the placenta — no direct fetal exposure
- Most effective glucose-lowering agent in pregnancy
- Dose can be precisely titrated to glucose levels
- Safe throughout all trimesters
- Required if metformin/glibenclamide fail to achieve targets
Starting Insulin Doses (GDM)
Starting dose (general)0.1–0.2 units/kg/day
Isolated fasting hyperglycaemiaIsophane (NPH) or glargine at bedtime
Post-meal hyperglycaemiaRapid-acting insulin before affected meal
Multiple excursionsBasal-bolus regimen
Titration increment2 units every 3 days per glucose pattern
Insulin Regimens
| Regimen | Insulin Type | Indication | Key Nursing Notes |
|---|---|---|---|
| Bedtime basal only | NPH (Isophane) or Glargine | Fasting hyperglycaemia only; post-meal values within target | Give at consistent time nightly. Rotate sites. Monitor for nocturnal hypoglycaemia. |
| Pre-meal rapid-acting | Lispro / Aspart / Glulisine | Post-meal spikes at 1 or 2 specific meals | Give 0–15 min before meal. Match dose to carbohydrate load. Skip dose if not eating. |
| Basal-bolus | Basal (night) + rapid-acting (meals) | Both fasting and post-meal hyperglycaemia; complex patterns | Most physiological. Requires patient education on carbohydrate counting. Higher hypoglycaemia risk. |
| Twice-daily mixed | Biphasic (e.g. 30/70 mix) | Simpler regimen for adherence concerns | Fixed carbohydrate meals required. Less flexible. Some GCC centres use for simplicity. |
Oral Agents (where used in GCC)
Metformin
- Crosses the placenta — fetal exposure occurs
- Long-term data (MiG trial and follow-up) reassuring but not conclusive
- Not UK first-line but used in some GCC centres as adjunct or second-line
- Useful in obese women — reduces maternal weight gain
- GI side effects — take with meals
- Not suitable if eGFR <45, hepatic impairment, or dehydration risk
- Always inform patient that insulin may still be needed
Glibenclamide (Glyburide)
- Second-generation sulphonylurea
- Used in some GCC centres where insulin is declined or access limited
- Crosses placenta — associated with neonatal hypoglycaemia risk
- Higher macrosomia rates compared to insulin in some studies
- Not recommended by NICE or ACOG as preferred agent
- If used: monitor neonatal glucose closely after delivery
Insulin Injection Technique in Pregnancy
Injection Sites & Technique
- Abdomen: safe in early–mid pregnancy; avoid within 5cm of umbilicus and fundal area as uterus grows
- Outer thighs: preferred site in late pregnancy when abdomen is less accessible
- Upper outer arms: can be used but requires skin pinching
- Buttocks: acceptable alternative
- Rotate sites systematically to prevent lipohypertrophy
- Inject into subcutaneous tissue — use 4mm or 6mm pen needle
- Do not inject into lipohypertrophic tissue — erratic absorption
- Discard needles safely — sharps disposal essential
- Store insulin correctly: opened vials at room temp ≤28 days; unopened in fridge
Hypoglycaemia in Pregnancy
Hypoglycaemia Recognition & Treatment
Threshold: Blood glucose <3.5 mmol/L (<63 mg/dL). Pregnancy lowers counter-regulatory response — hypoglycaemia is more dangerous and may occur with fewer warning signs.
Symptoms to teach patient:
- Shakiness / trembling
- Sweating, pallor
- Palpitations
- Dizziness / lightheadedness
- Hunger / nausea
- Confusion (severe)
- Loss of consciousness (emergency)
Rule of 15 Treatment:
Take 15g fast-acting carbohydrate immediately (see options below)
Rest and wait 15 minutes
Recheck blood glucose
If still <3.5 mmol/L: repeat 15g carbohydrate
Once resolved: eat a small snack containing complex carbohydrate + protein
If on insulin: contact diabetes team — dose review needed
15g Fast-Acting Carbohydrate Options (GCC Context)
4–5 glucose tablets
150ml fruit juice (no added sugar)
3 teaspoons sugar in water
6–7 gummy sweets
1 small banana
NOT dates (too slow)
NOT chocolate (fat slows absorption)
Sick Day Rules
Managing GDM During Illness
- Never stop insulin during illness — insulin requirements often increase
- Monitor blood glucose every 2–4 hours when unwell
- Test urine or blood for ketones if BGL >11 mmol/L or unable to eat
- Maintain hydration — sip fluids containing carbohydrate if unable to eat solids
- Ketonaemia in pregnancy is dangerous even at lower glucose levels — seek medical review early
- Vomiting preventing all oral intake → attend hospital immediately for IV fluids and insulin management
- Contact diabetes team / emergency services if ketones positive + vomiting + high BGL
Monitoring principle: GDM increases risks for both mother and fetus. Structured surveillance detects complications early and guides timing of delivery.
Maternal Complications
Pre-eclampsia
2× increased risk in GDM. Screen at every visit: BP, urine protein, symptoms (headache, visual disturbance, epigastric pain). Consider aspirin 150mg from 12 weeks in high-risk.
Polyhydramnios
Fetal hyperglycaemia → osmotic diuresis → excess amniotic fluid. Monitor AFI (Amniotic Fluid Index) on USS. Increases risk of cord prolapse and malpresentation.
Urinary Tract Infections
Glucosuria promotes bacterial growth. MSU at booking and any symptomatic episode. Treat all bacteriuria in pregnancy (even asymptomatic). Recurrent UTI — consider prophylaxis.
Fetal Complications
Macrosomia & Shoulder Dystocia
- Macrosomia defined as EFW >4kg or >90th centile
- Fetal hyperinsulinaemia drives excess fat deposition (especially truncal)
- USS EFW every 4 weeks from 28 weeks (28, 32, 36 weeks)
- EFW >4.5 kg on insulin → consider elective caesarean section (ERCS)
- Shoulder dystocia risk escalates exponentially above 4.5 kg
HELPERR Mnemonic (Shoulder Dystocia)
- H — Call for Help
- E — Evaluate for episiotomy
- L — Legs (McRoberts manoeuvre)
- P — Suprapubic pressure
- E — Enter (internal rotational manoeuvres)
- R — Remove the posterior arm
- R — Roll the patient (all-fours)
Other Fetal Risks
- Neonatal hypoglycaemia — most common neonatal complication (see Tab 5)
- Respiratory distress syndrome — impaired surfactant production
- Neonatal hyperbilirubinaemia (jaundice)
- Polycythaemia (high haematocrit from fetal hypoxia)
- Stillbirth risk — 2–3× higher than general population in poorly controlled GDM
- Long-term: offspring at higher risk of childhood obesity and T2DM
Fetal Monitoring Schedule
Growth USS28, 32, 36 weeks (every 4 wks from 28w)
Fetal kick chartFrom 28 weeks — report <10 movements in 12h
CTG38–40 weeks if insulin-controlled
AFI assessmentEach growth USS — monitor polyhydramnios
Placenta locationConfirm at 20-week anomaly scan
Timing of Delivery (IOL)
| GDM Type | Recommended Delivery Timing | Rationale |
|---|---|---|
| Diet-controlled GDM (no medication) | Offer IOL by 40+6 weeks | Risk of stillbirth increases beyond term; vaginal birth possible |
| Insulin-controlled GDM | Offer IOL at 38–40 weeks | Macrosomia risk; insulin resistance peaks late third trimester |
| EFW >4.5 kg on insulin | Discuss ERCS at 38 weeks | Shoulder dystocia risk; document counselling and patient choice |
| Additional complications (pre-eclampsia, IUGR) | Individualised — obstetric decision | May require earlier delivery |
Intrapartum Glucose Management
Labour & Delivery Glucose Protocol
Target BGL in labour4.0–7.0 mmol/L
BGL monitoring frequencyHourly during active labour
Diet-controlled in labourBGL monitoring only; insulin rarely needed
Insulin-controlled in labourDextrose-insulin infusion protocol
IV Dextrose + Insulin Infusion (if BGL outside 4–7 range):
- 5% or 10% dextrose infusion with variable rate insulin infusion (VRIII)
- Adjust insulin rate per local sliding scale protocol
- Avoid hypoglycaemia in labour — fetal distress risk
- Continue monitoring post-delivery until oral intake established
Stop long-acting insulin on the morning of planned IOL or ERCS. Resume or discontinue postnatally based on BGL readings (see Tab 5).
Key message: GDM resolves in the majority of women at delivery. However, the postnatal period carries significant risks for the neonate, and the mother has a 30–40% lifetime risk of developing T2DM within 10 years.
Immediate Postnatal — Maternal Management
Insulin Cessation at Delivery
- Stop all insulin immediately at delivery of placenta — insulin resistance resolves rapidly
- Monitor BGL every 4 hours for first 24–48 hours postnatally
- If BGL remains elevated: check for pre-existing T2DM (not resolved GDM)
- Metformin / glibenclamide: stop at delivery; reassess at 6-week OGTT
- BGL target postnatal (if still monitoring): fasting <6.1 mmol/L
- Persistent hyperglycaemia postnatally → treat as T2DM until confirmed otherwise
Breastfeeding in GDM
- Strongly encourage breastfeeding — reduces neonatal hypoglycaemia risk
- Reduces maternal T2DM risk by up to 25% per year of breastfeeding
- Improves neonatal glucose homeostasis through colostrum (high-protein first feed)
- Metformin is present in breast milk in low concentrations — generally considered safe but discuss with patient
- Insulin does not pass into breast milk — safe to continue if needed postnatally
- Support early initiation within 1 hour of birth
Neonatal Hypoglycaemia
Neonatal Hypoglycaemia — Recognition & Management
All infants of GDM mothers (especially insulin-treated) must have neonatal glucose screening. Neonatal hypoglycaemia <2.0 mmol/L requires immediate treatment.
Screening Protocol:
First screen2–4 hours of life
Subsequent screensBefore feeds if <48h old
Normal neonatal BGL≥2.6 mmol/L
Treatment threshold<2.0 mmol/L
Treatment Steps:
Early and frequent feeding (breast or formula) — first feed within 1 hour of birth
Symptomatic or BGL <1.5 mmol/L → IV dextrose (10% dextrose 2ml/kg bolus)
Recheck BGL 30 minutes after intervention
Buccal dextrose gel (40%) can be used as first-line in some protocols
Admit to NICU/SCBU if BGL remains low or infant symptomatic (jitteriness, hypotonia, seizures)
Symptoms of neonatal hypoglycaemia: jitteriness, poor feeding, pallor/cyanosis, apnoea, hypotonia, seizures, irritability.
Postnatal OGTT & Long-Term Follow-Up
Postnatal Diabetes Screening
Postnatal OGTT timing6–12 weeks post-delivery
Test75g 2-hour OGTT (same as antenatal)
Risk of T2DM within 10 years30–40%
Annual follow-upFasting glucose annually if OGTT normal
HbA1c intervalEvery 1–3 years (post-breastfeeding)
Interpreting Postnatal OGTT:
| Result | Interpretation |
|---|---|
| Fasting <6.1 and 2h <7.8 | Normal |
| Fasting 6.1–6.9 and/or 2h 7.8–11.0 | Pre-diabetes (IFG/IGT) |
| Fasting ≥7.0 or 2h ≥11.1 | T2DM — refer to diabetologist |
Lifestyle Modification Post-GDM
- Weight loss of 5–7% body weight reduces T2DM progression by 50–58%
- Mediterranean-style diet or low-carbohydrate diet most evidence-based
- Minimum 150 min/week moderate aerobic activity
- Structured diabetes prevention programmes (e.g. NHS DPP equivalent in GCC)
- GCC-specific: sedentary lifestyle and high-carbohydrate diet are major modifiable risk factors
- Involve family in lifestyle change — GCC family-centred culture supports group behaviour change
Contraception & Future Pregnancy
- GDM recurrence risk: 30–50% in next pregnancy
- Counsel on recurrence and importance of preconception weight optimisation
- Contraception choice: progesterone-only pill or IUD preferred (combined OCP increases T2DM risk slightly)
- Ideal inter-pregnancy interval: 18–24 months minimum
- Preconception care if planning next pregnancy: optimise BMI, ensure HbA1c normal, folic acid 400–5000 mcg/day
- Women with post-GDM T2DM: pre-pregnancy insulin optimisation required
GCC Epidemic: GDM prevalence in GCC countries is 16–26% — among the highest recorded globally. This is driven by a constellation of genetic susceptibility, dietary transition, physical inactivity, and high obesity rates. Every GCC nurse must be equipped to manage GDM comprehensively.
GCC GDM Prevalence
UAE20–22%
Saudi Arabia24–26%
Qatar18–20%
Kuwait16–18%
Bahrain16–17%
Oman14–16%
Global average GDM prevalence: ~14%
Driving Factors in GCC
- Adult obesity prevalence 30–40%
- Sedentary lifestyle (car-dependent, indoor culture)
- High-carbohydrate traditional diet
- Genetic susceptibility — South Asian and Arab populations
- High IVF rate → multiple pregnancies
- Later age at first pregnancy
- T2DM family history extremely common
Government Programmes
- UAE: universal OGTT screening all pregnant women — MOH protocol
- Saudi Arabia: SFDA-endorsed national GDM guidelines
- Qatar: Hamad Medical Corporation integrated GDM pathway
- Kuwait: Ministry of Health antenatal screening mandate
- Bahrain/Oman: unified Gulf diabetes programmes
- All GCC countries: Arabic-language patient education materials available
Arabic Diet & GDM — Cultural Adaptations
Traditional Arabic Foods — GDM Guidance
| Food / Practice | GDM Impact | Nurse Advice |
|---|---|---|
| Dates (tamr) | High natural sugar (74g sugar/100g); high GI despite fibre content | Limit to 2–3 dates only, always paired with protein (e.g. nuts) to blunt glucose rise. Avoid date juice. |
| White rice (ruz) | High GI staple; large portions common | Portion to ½ cup cooked; mix with lentils (mejadra); consider basmati (lower GI); add vinegar/lemon to reduce GI |
| Arabic flatbread (khubz) | High GI; consumed in large quantities | Limit to 1 small piece per meal; prefer whole wheat variant; use to scoop high-protein dishes |
| Harees / Jareesh | Wheat-based; moderate GI; often cooked with ghee | Small portions; avoid added sugar versions; use olive oil instead of ghee |
| Mandi / Kabsa | Rice-based; large portions; cooking ghee/oil adds calories | Focus on meat/chicken component; small rice portion; high salad intake alongside |
| Luqaimat / Halwa | Very high sugar and fat — avoid entirely | Reserve for special occasions only; very small portions if unavoidable; check BGL after |
| Qahwa (Arabic coffee) | Unsweetened — no carbohydrate impact | Encourage over sugary drinks; advise against sweetened varieties (saffron qahwa with sugar) |
| Large family meals | Social pressure to overeat; large portions served | Eating strategy: fill half plate with salad/vegetables first; eat protein before rice; slow eating |
Ramadan Fasting in GDM
Ramadan Guidance for GDM Patients
Islamic guidance: Pregnant women are generally exempt from fasting (Quran 2:183–185). Nurses should sensitively communicate this and support the patient's informed decision.
Diet-Controlled GDM — may fast with:
- Close blood glucose monitoring (pre-Suhoor, 2h after Iftar)
- Frequent consultant review during Ramadan
- Suhoor: high-protein, low-GI, adequate hydration
- Iftar: avoid large sugar-rich meal immediately; start with dates (2–3) + water then pause before main meal
- Stop fasting and seek care if BGL <3.5 or >11 mmol/L, severe vomiting, reduced fetal movement
Insulin-Treated GDM — fasting not recommended:
- High risk of hypoglycaemia during long fasting hours (15–18h in summer GCC)
- Insulin dosing is complex during fasting — timing with Suhoor/Iftar requires specialist input
- If patient insists on fasting: involve diabetologist; adjust to basal-only regimen; cease rapid-acting insulin
- Basal insulin: shift to Suhoor timing if fasting
- BGL monitoring is permitted (does not break fast — IFSO/Islamic Fiqh ruling)
IVF & Multiple Pregnancies in GCC
- GCC has among the highest IVF utilisation rates globally
- Twin/triplet pregnancies from IVF significantly increase GDM risk
- Multiple pregnancy: screen at booking and repeat 24–28 weeks regardless of first result
- Twins: double the fetal glucose demand → higher insulin requirements
- Preterm delivery more common in multiples — neonatal team always alerted in GDM multiple pregnancies
Gestational Weight Gain Targets (GCC)
| Pre-pregnancy BMI | Recommended GWG |
|---|---|
| Underweight (<18.5) | 12.5–18 kg |
| Normal (18.5–24.9) | 11.5–16 kg |
| Overweight (25–29.9) | 7–11.5 kg |
| Obese (>30) — common in GCC | 5–9 kg |
Many GCC women commence pregnancy with BMI >30. Lower gestational weight gain targets are appropriate. Weight loss during pregnancy is NOT recommended.
GCC Nurse Education & Patient Communication Tips
- Use Arabic-language GDM booklets — available from MOH in all GCC countries
- Involve family members in education (husband, mother-in-law — influential in GCC)
- Address cultural beliefs: "sweet urine" myths, GDM as spiritual test
- Arabic word for diabetes: "مرض السكري" (Marad al-Sukari) — use this terminology
- WhatsApp-based glucose diary is widely accepted in GCC — encourage photo sharing with midwife
- Telemedicine widely available in GCC — utilise for rural/distant patients
- Peer support groups effective — GCC women respond well to community-based care
- Acknowledge that domestic helpers (common in GCC) cook family meals — include dietary education for household